Filters
reset allOther countries
Results: 1 to 6 of 6
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece | 16 | 52 |
|
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance by Next Generation Sequencing ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 1 | 2 |
|
NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States | 2 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
BCR-ABL Kinase Mutation Analysis Versiti Diagnostic Laboratories Versiti, Inc United States | 1 | 2 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Results: 1 to 6 of 6
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.